Lv4
732 积分 2023-07-21 加入
Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial
6天前
已完结
Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial
6天前
已完结
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
6天前
已完结
Minimally Invasive Surgery, Intraoperative Capsule Rupture, and Survival in Early Ovarian Cancer
6天前
已完结
Consolidative camrelizumab following definitive concurrent chemoradiotherapy with involved-field irradiation in locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial
9天前
已完结
Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma
12天前
已完结
Cell death in cancer
14天前
已完结
Endometrial Cancer
14天前
已完结
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
17天前
已完结
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
17天前
已完结
皖公网安备34019202002308
